Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Primary Care
For patients with obesity and elevated alk phos who have RA, do you check a fibroscan or serum NASH fibrosure test before starting methotrexate or leflunomide?
Related Questions
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
How do you approach managing nausea and GI side effects when initiating methotrexate?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
What is your approach to biologic therapy in older adults (80+) and CKD with RA?
How do you counsel patients with RA stable on csDMARDs on whether to attempt tapering or not?
Do you feel comfortable using Jak inhibitors in patients with a strong family history of CAD, but no other risk factors?
Do you generally find plain radiographs useful as part of your baseline evaluation in suspected rheumatoid arthritis?
What is your approach for cancer screening for elderly onset RA?
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
